Progression of a Structural Scoliosis During Treatment with Growth Hormone: A Case Report
DOI:
https://doi.org/10.3109/17453677809005763Abstract
A diagnosis of panhypopituitarism was made in an infantile male at the age of 22. Skeletal age was estimated to be 14 years. Thyroxin, corticosteroid and later testosterone was administered. Growth hormone was given initially over a period of ten weeks and later for two and a half years. The standing height increased from 143 to 158.5 cm. During periods of growth induced by growth hormone a progression of a thoracic scoliosis from 15° to 62° was observed. In this case growth hormone or the associated substances seem to be the more probable cause of the progression of scoliosis than growth rate per se.Downloads
Download data is not yet available.
Downloads
Published
1978-01-01
How to Cite
Dymling, J.-F., & Willner, S. (1978). Progression of a Structural Scoliosis During Treatment with Growth Hormone: A Case Report. Acta Orthopaedica, 49(3), 264–268. https://doi.org/10.3109/17453677809005763
Issue
Section
Articles
License
Acta Orthopaedica (Scandinavica) content is available freely online as from volume 1, 1930. The journal owner owns the copyright for all material published until volume 80, 2009. As of June 2009, the journal has however been published fully Open Access, meaning the authors retain copyright to their work. As of June 2009, articles have been published under CC-BY-NC or CC-BY licenses, unless otherwise specified.
PlumX (by Elsevier) is an altmetrics platform that tracks and visualizes the online attention, usage, captures, citations, and social media engagement.
